title: Development of thyroid dysfunction after alpha-interferon treatment of chronic hepatitis C.
authors.forename: J
authors.initials: J
authors.lastname: Primo
authors.forename: J
authors.initials: J
authors.lastname: Hinojosu
authors.forename: J R
authors.initials: JR
authors.lastname: Molés
authors.forename: J
authors.initials: J
authors.lastname: Fernández
authors.forename: C
authors.initials: C
authors.lastname: Martinez
authors.forename: A
authors.initials: A
authors.lastname: Miralles
authors.forename: A
authors.initials: A
authors.lastname: Otte
mesh_terms: D000328:Adult; D005260:Female; D006526:Hepatitis C / Q000628:therapy*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000009:adverse effects* / Q000627:therapeutic use; D008297:Male; D011994:Recombinant Proteins; D013960:Thyroid Function Tests; D013967:Thyroiditis, Autoimmune / Q000209:etiology*
chemical_list: D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins